63 results about "Bornyl acetate" patented technology

A process for extracting the medical components from chrysanthemum flower includes such steps as adding dried chrysanthemum flower to medical alcohol, putting in volatile oil extractor, thermal reflux extracting twice (1-2 hr for each time), vacuum concentrating at 40-60 deg.c, adding water to its dregs, thermal reflux extracting twice, vacuum concentrating, collecting the concentrated liquid, concentrating and drying. The obtained extract contains alpha-pinene, alpha-terpineol, bornyl acetate, apiin, luteolin and chlorogenic acid, and can be individually used as medicine.

The invention provides an eye-clearing composition, eye drops containing the same and a preparation method of the eye drops. According to the eye-clearing composition provided by the invention, borneol liquid and borneol camphor extract contain active components including borneol, eucalyptol, camphor, bornyl acetate, alpha-pinene, limonene, beta-myrcene, alpha-terpilenol, linalool, beta-pinene andalpha-caryophyllene; the active components can be used for opening channels of eye skin, promoting effective components in folium ginkgo extract, lily bulb extract, herba menthae extract, yellow chrysanthemum extract and bilberry fruit extract to permeate into bottom-layer skin of eyes, promoting the metabolism of the skin, alleviating eye fatigue, removing free radicals and resisting wrinkles and resisting ageing. According to the preparation method provided by the invention, active components in borneol camphor branches and leaves are sufficiently extracted, active components including total flavonoids and ginkgolides in folium ginkgo are sufficiently extracted and an active compound, i.e., a phenolic acid glyceride glycoside compound, is sufficiently extracted; the preparation method provided by the invention has the advantages that the target active substance is sufficiently extracted and the extraction efficiency is high.

The invention provides a compound borneol antibacterial agent, and belongs to the technical field medicine preparations. The antibacterial agent includes, mass percentage, 85-90% of bornyl acetate, 2.5-5% of limonene, 5-10% of borneol, and 1-1.5% of methyl salicylate. The provided antibacterial agent is significant in bacteriostatic and bactericidal effects, can be used for inhibiting and killingstaphylococcus aureus, candida albicans and Escherichia coli, and has antibacterial broad spectrum and extensive applicability; and the antibacterial agent can treat infectious skin diseases caused byvarious fungi or bacteria, alleviate wound infection, has no nontoxicity and no irritation on skins and is safe and effective.

The present disclosure provides compositions and methods for using topical, isotonic compositions comprising a prebiotic oligosaccharide, a metal co-factor, and an essential oil comprising bornyl acetate. The compositions support the genital microbiota and are useful for, for example, hydrating, lubricating, cleaning, and / or decreasing irritation or inflammation of the urogenital and / or anogenital region of a subject, and / or enhancing the beneficial genital microbiota of a subject. Such compositions are useful before, during, and / or after sexual and / or reproductive activity.

The invention discloses fructus amomi ultrafine powder and a preparation method thereof. When the ultrafine powder is prepared, the preparation method comprises the steps that firstly, fructus amomi dry products are crushed, soaked in liquid nitrogen for a period of time, and then conventionally ground to 50-60 meshes, and fructus amomi coarse powder is obtained; then the fructus amomi coarse powder and auxiliary materials comprising talcum powder, mannitol, camphor and bornyl acetate are evenly mixed according to the mass ratio being of (50-100) to :1, and thus mixed powder is obtained; and then the mixed powder is put into an ultrafine grinder to be ground for 20-30 minutes under the anhydrous condition, thus the fructus amomi ultrafine powder is obtained, and finally, the fructus amomiultrafine powder is dried and sterilized to obtain a finished product. By adopting the preparation method, fructus amomi, especially amomum longiligulare, can be ground into the evenly-distributed fructus amomi ultrafine powder with the fine grain size, the obtained fructus amomi fine powder has the high contents of volatile oil and the bornyl acetate and can be directly used as medicine, waste ofactive ingredients in the fructus amomi is avoided, and the overall utilization rate of the fructus amomi is increased.

The invention relates to medicine and the chemical and pharmaceutical industry and to agents for treating diseases caused by angiogenesis regulation disorders, in particular to a method for treating oncological diseases of different genesis by inducing angiogenesis inhibition which is secondary to the direct antitumoral, anti-reccurant and anti-metastatic action as well as by the associated activation of the apoptosis endogenous system. The invention uses a novel peroral medicinal form 'Abisilin', comprising ingredients relating to the class of natural terpene compounds (isoprenoids), produced from coniferous threes of a Pinaceae family, which medicinal form contains: sesquiterpenoids (3-6%), neutral diterpenoids (11-15%), diterpene acids (22-28%), triterpene acids (8-16%), unsaturated and saturated fatty acids (0.1-0.3%), phenolic compounds (0.1-0.2%), monoterpenoids being the rest, wherein the bornyl acetate content is equal to not less that 10.0% of the total terpene composition. It is expected that the use of the novel peroral medicinal form 'Abisilin', the substance of which exhibits immunomodulating, antibacterial, antiinflammatory, anesthetic, wound-healing and other pharmacologically-significant actions, is free of contra-indications and toxic effects and can be used together with different agents, provides a novel therapeutic approach and enhances the efficiency of treatment of oncological and many other diseases caused by angiogenesis process disorders.